267 related articles for article (PubMed ID: 35306982)
1. Thiazole and Related Heterocyclic Systems as Anticancer Agents: A Review on Synthetic Strategies, Mechanisms of Action and SAR Studies.
Sahil ; Kaur K; Jaitak V
Curr Med Chem; 2022 Aug; 29(29):4958-5009. PubMed ID: 35306982
[TBL] [Abstract][Full Text] [Related]
2. Recent Development in Indole Derivatives as Anticancer Agents for Breast Cancer.
Kaur K; Jaitak V
Anticancer Agents Med Chem; 2019; 19(8):962-983. PubMed ID: 30864529
[TBL] [Abstract][Full Text] [Related]
3. Recent Developments in Oxazole Derivatives as Anticancer Agents: Review on Synthetic Strategies, Mechanism of Action and SAR Studies.
Kulkarni S; Kaur K; Jaitak V
Anticancer Agents Med Chem; 2022; 22(10):1859-1882. PubMed ID: 34525925
[TBL] [Abstract][Full Text] [Related]
4. Synthetic and Medicinal Perspective of Fused-Thiazoles as Anticancer Agents.
Pawar S; Kumar K; Gupta MK; Rawal RK
Anticancer Agents Med Chem; 2021; 21(11):1379-1402. PubMed ID: 32723259
[TBL] [Abstract][Full Text] [Related]
5. Thiazole-Based Thiosemicarbazones: Synthesis, Cytotoxicity Evaluation and Molecular Docking Study.
Gomha SM; Abdelhady HA; Hassain DZH; Abdelmonsef AH; El-Naggar M; Elaasser MM; Mahmoud HK
Drug Des Devel Ther; 2021; 15():659-677. PubMed ID: 33633443
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of imidazo[2,1-b]thiazole-based anticancer agents in one decade (2011-2020): Current status and future prospects.
Sbenati RM; Semreen MH; Semreen AM; Shehata MK; Alsaghir FM; El-Gamal MI
Bioorg Med Chem; 2021 Jan; 29():115897. PubMed ID: 33316752
[TBL] [Abstract][Full Text] [Related]
7. A Medicinal Chemist's Perspective Towards Structure Activity Relationship of Heterocycle Based Anticancer Agents.
Nehra B; Mathew B; Chawla PA
Curr Top Med Chem; 2022; 22(6):493-528. PubMed ID: 35021975
[TBL] [Abstract][Full Text] [Related]
8. Some Thiazole Derivatives Combined with Different Heterocycles: Cytotoxicity Evaluation and Apoptosis Inducing Studies.
Yurttaş L; Demir B; Çiftçi GA
Anticancer Agents Med Chem; 2018; 18(8):1115-1121. PubMed ID: 29595114
[TBL] [Abstract][Full Text] [Related]
9. Anticancer Potential of Thiazole Derivatives: A Retrospective Review.
Jain S; Pattnaik S; Pathak K; Kumar S; Pathak D; Jain S; Vaidya A
Mini Rev Med Chem; 2018; 18(8):640-655. PubMed ID: 29173166
[TBL] [Abstract][Full Text] [Related]
10. Isoxazole derivatives as anticancer agent: A review on synthetic strategies, mechanism of action and SAR studies.
Arya GC; Kaur K; Jaitak V
Eur J Med Chem; 2021 Oct; 221():113511. PubMed ID: 34000484
[TBL] [Abstract][Full Text] [Related]
11. One-Pot Synthesis of Novel Thiazoles as Potential Anti-Cancer Agents.
Sayed AR; Gomha SM; Taher EA; Muhammad ZA; El-Seedi HR; Gaber HM; Ahmed MM
Drug Des Devel Ther; 2020; 14():1363-1375. PubMed ID: 32308369
[TBL] [Abstract][Full Text] [Related]
12. A Review on the Synthesis and Anticancer Potentials of Imidazothiazole Derivatives.
Kamboj P; Mahore A; Husain A; Shaquiquzzaman M; Alam MM; Amir M
Mini Rev Med Chem; 2023; 23(17):1733-1759. PubMed ID: 36722483
[TBL] [Abstract][Full Text] [Related]
13. A Review on Anticancer Potentials of Benzothiazole Derivatives.
Pathak N; Rathi E; Kumar N; Kini SG; Rao CM
Mini Rev Med Chem; 2020; 20(1):12-23. PubMed ID: 31288719
[TBL] [Abstract][Full Text] [Related]
14. Thiazole-containing compounds as therapeutic targets for cancer therapy.
Sharma PC; Bansal KK; Sharma A; Sharma D; Deep A
Eur J Med Chem; 2020 Feb; 188():112016. PubMed ID: 31926469
[TBL] [Abstract][Full Text] [Related]
15. Eco-friendly sequential one-pot synthesis, molecular docking, and anticancer evaluation of arylidene-hydrazinyl-thiazole derivatives as CDK2 inhibitors.
El-Naggar AM; El-Hashash MA; Elkaeed EB
Bioorg Chem; 2021 Mar; 108():104615. PubMed ID: 33484942
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel thiazole-naphthalene derivatives as potential anticancer agents and tubulin polymerisation inhibitors.
Wang G; Liu W; Fan M; He M; Li Y; Peng Z
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1694-1702. PubMed ID: 34309466
[TBL] [Abstract][Full Text] [Related]
17. A New Series of Antileukemic Agents: Design, Synthesis, In Vitro and In Silico Evaluation of Thiazole-Based ABL1 Kinase Inhibitors.
Zeytün E; Altıntop MD; Sever B; Özdemir A; Ellakwa DE; Ocak Z; Ciftci HI; Otsuka M; Fujita M; Radwan MO
Anticancer Agents Med Chem; 2021; 21(9):1099-1109. PubMed ID: 32838725
[TBL] [Abstract][Full Text] [Related]
18. New Approaches for the Synthesis of 2,3,5,6-Tetrahydrobenzo[d]thiazole Derivatives and their Anti-Proliferative, c-Met Enzymatic Activity and Tyrosine Kinases Inhibitions.
Mohareb RM; Helal MHE; Mohamed SS; Abdallah AEM
Anticancer Agents Med Chem; 2022; 22(12):2327-2339. PubMed ID: 34951581
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Biological Evaluation of 2-Substituted Benzyl-/Phenylethylamino-4-amino-5-aroylthiazoles as Apoptosis-Inducing Anticancer Agents.
Oliva P; Onnis V; Balboni E; Hamel E; Estévez-Sarmiento F; Quintana J; Estévez F; Brancale A; Ferla S; Manfredini S; Romagnoli R
Molecules; 2020 May; 25(9):. PubMed ID: 32384805
[TBL] [Abstract][Full Text] [Related]
20. Bestowal of Quinazoline Scaffold in Anticancer Drug Discovery.
Das R; Mehta DK; Dhanawat M
Anticancer Agents Med Chem; 2021; 21(11):1350-1368. PubMed ID: 32593282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
